Bioequivalence of Yutanal® Capsule to Harnal® Capsule (Tamsulosin HCl 0.2 mg)
![]() |
Im, Ho-Taek
(College of Pharmacy, Kyung Hee University)
Cho, Sung-Hee (College of Pharmacy, Kyung Hee University) Lee, Heon-Woo (College of Pharmacy, Kyung Hee University) Park, Wan-Su (College of Pharmacy, Kyung Hee University) Kim, Young-Kwan (College of Pharmacy, Kyung Hee University) Rew, Jae-Hwan (Medical Center, Kyung Hee University) Lee, Kyung-Tae (College of Pharmacy, Kyung Hee University) |
1 | K.A. Lyseng-Williamson, B. Jarvis and A.J. Wagstaff, Tamsulosin: an update of its role in the management of lower urinary tract symptoms, Drugs, 62, 135-167 (2002) DOI ScienceOn |
2 | H. Matsushima, H. Kamimura, Y. Soeishi, T. Watanabe, S. Higuchi and M. Tsunoo, Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs, and humans, Drug Metab Dispos, 26, 240-245 (1998) |
3 | M. Wolzt, V. Fabrizii, G.T. Domer, G. Zanaschka, P. Leutkens, W.J. Krauwinkel and H.G. Eichler, Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label singledose and multiple-dose study, Eur. J. Clin. Pharmacol, 54, 367-373 (1998) DOI ScienceOn |
4 | K. Koiso, H. Akaza, K. Kikuchi, K. Aoyagi, S. Ohba, M. Miyazaki, M. Ito, T. Sueyoshi, H. Matsushima, H. Kamimura, T. Watanabe and S. Higuchi, Pharmacokinetics of tamsulosin hydrochloride in patients with renal impairment: effects of alpha 1-acid glycoprotein, J. Clin. Pharmacol, 36, 1029-1038 (1996) DOI ScienceOn |
5 | 식품의약안전청 고시 제 2002-60호(2002. 11. 22). 생물학적동등성시험기준 |
![]() |